CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8(+) T cells.
- DOI
- 10.1038/s41417-026-01078-9
- Published
- 2026 Aug 27
- Container
- Cancer gene therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41417-026-01078-9,
title = {CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8(+) T cells.},
author = {Zhang C and Wei Q and Rahim N and Bian G and Wu C and Wang J and Yang P and Hua J and Zhu M and Chen Y and Liu Y and Gao S and Hou B and Zhang W and Jing H},
year = {2026},
journal = {Cancer gene therapy},
doi = {10.1038/s41417-026-01078-9},
url = {https://doi.org/10.1038/s41417-026-01078-9}
}RIS
TY - JOUR TI - CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8(+) T cells. AU - Zhang C AU - Wei Q AU - Rahim N AU - Bian G AU - Wu C AU - Wang J AU - Yang P AU - Hua J AU - Zhu M AU - Chen Y AU - Liu Y AU - Gao S AU - Hou B AU - Zhang W AU - Jing H PY - 2026 JO - Cancer gene therapy DO - 10.1038/s41417-026-01078-9 UR - https://doi.org/10.1038/s41417-026-01078-9 ER -
APA
C, Z., Q, W., N, R., G, B., C, W., J, W., P, Y., J, H., M, Z., Y, C., Y, L., S, G., B, H., W, Z., & H, J. (2026). CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8(+) T cells.. Cancer gene therapy. https://doi.org/10.1038/s41417-026-01078-9
Source records
- pubmed · retrieved 2026-09-26T15:18:36.372Z